https://www.selleckchem.com/pr....oducts/tauroursodeox
patients, especially in those with concomitant CAD. We also evidenced that C-HDL enhanced monocyte to endothelial cell adhesion, indicating a potential pro-atherogenic role of C-HDL in atherosclerosis among T2DM patients. Trial registration https//register.clinicaltrials.gov , NCT04390711 Registered on 14 May 2020; Retrospectively registered. Our study identified elevated carbamylation modification of HDL from T2DM patients, especially in those with concomitant CAD. We also evidenced that C-HDL enhanced monocyte to end